Financial Year |
March 31 2023 |
Monetary Funds |
147,578,019.16 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
13,293,954.00 |
Accounts Receivable |
246,372,825.40 |
Advances to Suppliers |
11,253,320.73 |
Other Receivables |
4,309,513.40 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
91,228,616.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
470,998.71 |
Total Current Assets |
544,118,963.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
2,554,116.30 |
Long-term Equity Investment |
101,595,053.93 |
Investment Properties |
39,800,330.08 |
Fixed Assetes |
112,625,682.77 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
28,583,412.19 |
R&D expenses |
-- |
Goodwill |
254,096,045.37 |
Long-Term Deferred and Prepaid Expenses |
9,207,130.34 |
Deferred Income Tax Assets |
3,934,809.92 |
Other Non-Current Assets |
1,765,300.00 |
Sub-Total of Non-Current Assets |
593,866,115.07 |
Total Assets |
1,137,985,078.15 |
Short-Term Loans |
7,300,000.00 |
Trading Financial liabilities |
-- |
Notes Payable |
9,365,624.75 |
Accounts Payable |
72,051,076.12 |
Accounts Received In Advance |
10,276,510.07 |
Employee Compensation Payable |
6,522,526.99 |
Taxes Payable |
7,839,592.35 |
Interest Payable |
-- |
Dividend Payable |
598,991.05 |
Other payables |
31,257,282.41 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,584,684.44 |
Other Current Liabilities |
2,951,787.49 |
Sub-Total of Current Liabilities |
176,543,608.02 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
994,617.39 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
3,584,333.30 |
Total Liabilities |
180,127,941.32 |
Paid-In Capital(Or Share Stock) |
524,198,348.00 |
Capital Surplus |
784,881,409.25 |
Surplus Reserve |
33,994,377.93 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-393,056,357.32 |
Minority Stockholder's Interest |
8,939,358.97 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
948,917,777.86 |
Owner's Equity(Stockholder's Equity) |
957,857,136.83 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,137,985,078.15 |